Literature DB >> 29027708

Advancing Prenatal Detection of Congenital Heart Disease: A Novel Screening Protocol Improves Early Diagnosis of Complex Congenital Heart Disease.

Karen M Letourneau1, David Horne2, Reeni N Soni1, Keith R McDonald3, Fern C Karlicki3,4, Randy R Fransoo5.   

Abstract

OBJECTIVES: Prenatal diagnosis of complex congenital heart disease (CHD) during routine obstetric ultrasound (US) examinations improves postnatal outcomes, but sensitivity is low (<40%). Our objective was to improve our prenatal detection of complex CHD with implementation of a specific screening protocol.
METHODS: From January 2003 to December 2013, 506 consecutive confirmed cases of complex CHD in the province of Manitoba, Canada, were analyzed to compare the sensitivity and positive predictive value of prenatal US detection of complex CHD before and after the introduction of a novel prenatal screening protocol. The intervention was done in October 2004, emphasizing screening and not diagnosis of complex CHD. It involved education, practical scanning tips, a checklist, and feedback on cases. We also assessed the effect of the intervention in different screening settings: community hospitals, tertiary hospitals, and fetal assessment units.
RESULTS: The sensitivity for detecting complex CHD increased from 29.8% to 88.3% (P < .0001), while the positive predictive value remained high. The largest improvement in detection was found for US units in community hospitals (52.4% higher; P < .0001), followed by tertiary hospitals (39.9%; P = .0004), and fetal assessment units (7.2%; P = .16). Additionally, there was a significant decrease in the presentation of neonates in critical condition from before to after the implementation (24.3% to 13.1%, respectively; P = .0165).
CONCLUSIONS: Implementing a focused routine prenatal screening protocol can vastly improve detection rates of critical cardiac abnormalities. The improvement in community hospitals was particularly important because early detection ensured that the birth was planned to take place in an appropriate facility. Our novel protocol can be performed by all sonographers, regardless of experience, equipment used, and hospital setting.
© 2017 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  congenital heart disease; echocardiography (fetal); education; obstetrics; prenatal diagnosis; screening for complex congenital heart disease

Mesh:

Year:  2017        PMID: 29027708     DOI: 10.1002/jum.14453

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  5 in total

Review 1.  Insights into Cardiovascular Defects and Cardiac Epigenome in the Context of COVID-19.

Authors:  Shreya Sarkar; Rwik Sen
Journal:  Epigenomes       Date:  2022-04-21

2.  Why are congenital heart defects being missed?

Authors:  A E L van Nisselrooij; A K K Teunissen; S A Clur; L Rozendaal; E Pajkrt; I H Linskens; L Rammeloo; J M M van Lith; N A Blom; M C Haak
Journal:  Ultrasound Obstet Gynecol       Date:  2020-06       Impact factor: 7.299

3.  A Framework for AI-Assisted Detection of Patent Ductus Arteriosus from Neonatal Phonocardiogram.

Authors:  Sergi Gómez-Quintana; Christoph E Schwarz; Ihor Shelevytsky; Victoriya Shelevytska; Oksana Semenova; Andreea Factor; Emanuel Popovici; Andriy Temko
Journal:  Healthcare (Basel)       Date:  2021-02-05

4.  The Mathematical Limitations of Fetal Echocardiography as a Screening Tool in the Setting of a Normal Second-Trimester Ultrasound.

Authors:  Samuel Bellavance; Mikhail-Paul Cardinal; Laurence Gobeil; Marie-Eve Roy-Lacroix; Frédéric Dallaire
Journal:  CJC Open       Date:  2021-06-18

5.  Incremental Detection of Severe Congenital Heart Disease by Fetal Echocardiography Following a Normal Second Trimester Ultrasound Scan in Québec, Canada.

Authors:  Mikhail-Paul Cardinal; Marie-Hélène Gagnon; Cassandre Têtu; Francis-Olivier Beauchamp; Louis-Olivier Roy; Camille Noël; Laurence Vaujois; Tiscar Cavallé-Garrido; Jean-Luc Bigras; Marie-Ève Roy-Lacroix; Frederic Dallaire
Journal:  Circ Cardiovasc Imaging       Date:  2022-04-04       Impact factor: 8.589

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.